Mr.Oxley’s remit includes establishing Cytori subsidiaries and commercial sales and distribution activities across Latin America, Africa, India, Thailand, Malaysia, Australia and New Zealand. Prior to accepting this role in support of Cytori’s strategic growth plans, Mr. Oxley served as Vice President of Marketing. In a marketing capacity, Mr. Oxley developed and directed an operational marketing team responsible for tactical marketing and sales support functions for Cytori’s global sales organization, including the E.U, Japan, and the U.S.
Prior to Cytori, Mr. Oxley served as Executive Vice President of World-Wide Sales & Marketing for the Point-of-Care Division for Trinity Biotech, plc (NASDAQ: “TRIB”),a public company specializing in the development, manufacture and marketing of clinical diagnostic products. Mr. Oxley had global responsibility for point-of-care market segments in addition to the development of an over-the-counter consumer market strategic business unit. In addition to his sales and marketing role, Mr. Oxley served as head of U.S. investor relations.
Prior to Trinity Biotech, Mr. Oxley served a combined sixteen years in leadership positions in the IVD market, including head of government relations or a medical device company, healthcare investment banking for a national bank, healthcare advocacy and lobbying for a Washington, D.C. lawfirm, and health-care policy work for a member of the United States House of Representatives
In concert with his corporate experiences, Mr. Oxley served in professional and not-for- profit entities including delegate of the Private Sector Delegation to the Board of the Global Fund to Fight HIV, TB& Malaria, outside director on the Board of the Children’s AIDS Fund and past member of the National Association of Securities Dealers, United States Army National Guard, and United States Air Force Reserve.